The Ghana Rare Disease Corporate Alliance is a coalition of rare disease industry stakeholders that are committed to collaboration between industry and patient communities to improve and expedite access to diagnosis and effective therapies for all rare patients.

Membership is open to laboratories, pharmaceutical, biotech companies and other corporate organisations that are committed to support education, community building and improved access to diagnostics, research and treatments for rare diseases.